Clinical trials
Pulmonary clinical trials
Below are recruiting pulmonary clinical trials, each written for real people, not researchers. We’re tracking 1,310 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05824871RecruitingPhase 3
Oral drug for rifampicin-resistant lung tuberculosis
This Phase 3 trial tests an oral medicine (Sudapyridine/WX-081) to treat people with rifampicin-resistant pulmonary tuberculosis. It compares how well the study drug works when you stop prior tuberculosis medicines and go through a short “washout” period first.
Beijing, Beijing MunicipalityAges 18–65 - NCT05841615Recruiting
Atrial fibrillation and high blood pressure ablation plus kidney nerve treatment
This trial tests whether treating atrial fibrillation with a catheter procedure plus treating high blood pressure through kidney nerve treatment works better together. It may help control rhythm and blood pressure, but you must meet several heart, kidney-artery, and safety requirements.
Xiamen, FujianAges 18–75 - NCT05842681Recruiting
Azithromycin for early worsening of idiopathic pulmonary fibrosis
This trial studies whether adding azithromycin to standard care can help people whose idiopathic pulmonary fibrosis is starting to flare up (worsen) in the early stages. It’s mainly for adults who are not very sick and cannot require intensive breathing support.
AsyutAges 18–80 - NCT05873387Recruiting
Stethoscope tool to detect pulmonary hypertension
This study tests a computer “listening” algorithm that uses an electronic stethoscope to help detect pulmonary hypertension. It may help spot this condition earlier by turning routine heart-lung exams into more informative screenings.
Providence, Rhode IslandAges 18 years+ - NCT05890729RecruitingPhase 1/Phase 2
XTMAB-16 for lung sarcoidosis that still causes breathing trouble
This early-phase study tests XTMAB-16 to improve lung sarcoidosis in people who still have symptoms despite standard steroid-type treatment. It may help reduce inflammation and improve breathing, while also learning the safest dose and how the treatment works in humans.
Birmingham, AlabamaAges 18–80 - NCT05891886RecruitingEarly Phase 1
Testing supplemental oxygen for early blood clot in the lungs
This early-phase trial studies whether giving extra oxygen can help people with a recently diagnosed lung blood clot (pulmonary embolism). It mainly looks at people who have early symptoms and signs that the right side of the heart is under strain.
Boston, MassachusettsAges 18 years+ - NCT05896579Recruiting
Study heart function during rest and exercise in COPD
This study measures how well the right side of your heart works when you are resting and when you exercise, in people with chronic obstructive pulmonary disease (COPD). It may help researchers better understand COPD-related heart strain and guide future care.
Aurora, ColoradoAges 40 years+ - NCT05896800Recruiting
Inhaled nitric oxide for moderate to severe COPD symptoms
This study tests whether inhaled nitric oxide gas can improve outcomes in people with moderate-to-severe chronic obstructive pulmonary disease (COPD). It may help reduce breathing problems by targeting how airways and blood vessels respond in the lungs.
Nanjing, JiangsuAges 40–75 - NCT05937191RecruitingPhase 1/Phase 2
Leflunomide for childhood idiopathic lung bleeding
This trial tests whether leflunomide can safely help children with idiopathic pulmonary hemosiderosis (a condition where the lungs bleed, and iron builds up). The study is mainly about safety and early signs of benefit in young patients.
Guangzhou, GuangdongAges 5 months–18 years - NCT05937854RecruitingPhase 2
Tadalafil to help breathing in COPD with pulmonary hypertension
This Phase 2 study tests whether tadalafil can improve breathlessness in people with COPD and pulmonary hypertension (high blood pressure in the lungs). It may help you breathe more easily if your symptoms are driven by this specific lung circulation problem.
Aurora, ColoradoAges 35–89 - NCT05968898Recruiting
Computer helps analyze lung nodules on CT scans
This study tests a computer tool that uses patterns from your chest CT scan to help assess an unclear lung nodule. It may help doctors decide which nodules need closer attention.
Philadelphia, PennsylvaniaAges 35–89 - NCT05975983RecruitingPhase 2
Oral treatment test for idiopathic pulmonary fibrosis
This Phase 2 study tests whether an oral medication (INS018_055) can help people with idiopathic pulmonary fibrosis (IPF). You may be a fit if your lung function is in a certain range and your condition is stable.
Birmingham, AlabamaAges 40 years+ - NCT05977803Recruiting
MRI study of brain radiation injury in lung cancer
This study looks at how a specific kind of MRI picture (called the CEST sequence) can help characterize radiation-related brain injury and changes in brain metastases from lung cancer. It may help doctors better interpret follow-up scans after radiation, without changing your cancer treatment.
ParisAges 18 years+ - NCT05989139Recruiting
Oxygen mask vs. breathing machine for sudden fluid in the lungs
This trial compares two ways to help people who have a sudden buildup of fluid in the lungs (acute pulmonary edema) breathe easier. One uses a simple oxygen mask, the other uses a machine that pushes air into your lungs. The results may help doctors choose the best treatment for you.
RomaAges 18 years+ - NCT05989698Recruiting
Validating a wearable cough monitor (C-mo)
This study tests a wearable device (C-mo) that monitors coughing. It is for people of all ages who are currently coughing and can cooperate with wearing a small sensor on their belly for a short time.
AlfenaAges 2 years+ - NCT06010563Recruiting
Study of a new heart valve for severe pulmonary valve leakage
This study tests a new less-invasive heart valve (VenusP-Valve) for people whose own pulmonary valve is leaking severely. If you qualify, you could get the new valve without open-heart surgery.
Irvine, CaliforniaAges 12 years+ - NCT06037096Recruiting
Structured follow-up after pulmonary embolism
This study tests a structured follow-up program for people who have had a pulmonary embolism. The program aims to help you recover better after your clot and lower the chance of future problems.
AalborgAges 18 years+ - NCT06038630RecruitingPhase 2
Xenon gas MRI study for lung and heart health
This study uses a special MRI scan (Xenon gas imaging) to look at how well your lungs and heart are working. It is for people with certain lung conditions, those getting blood transfusions or phlebotomy, or healthy volunteers.
Durham, North CarolinaAges 18 years+ - NCT06056999Recruiting
New method to identify lung nodule type
This study is testing a new method to help tell whether a lung nodule is benign (non-cancerous) or malignant (cancerous). It is for people who already need a biopsy or surgery for their lung nodule.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06078436Recruiting
Early carvedilol for heart failure shock
This trial tests whether starting the heart failure medication carvedilol early, along with standard monitoring, can help people in cardiogenic shock (when the heart can't pump enough blood) due to a weak heart muscle. It aims to see if earlier treatment improves outcomes.
SeoulAges 19 years+ - NCT06114667Recruiting
Nasal high flow vs. mask for COPD flare-up
This study compares two types of breathing support for people having a severe COPD flare-up with high carbon dioxide and acidic blood. It tests if a gentle air flow through the nose (nasal high flow) works as well as a mask (non-invasive ventilation) to help you breathe better.
Montpellier, MontepllierAges 18–85 - NCT06122233Recruiting
Digital self-management for fibrotic lung disease
This trial tests whether a digital self-management program (using a smartphone or tablet) helps people with fibrotic interstitial lung disease better manage their symptoms and quality of life. If you have this lung condition and can use a mobile device, this study could offer you extra support at home.
Sydney, New South WalesAges 18 years+ - NCT06125327RecruitingPhase 2/Phase 3
SC1011 for idiopathic pulmonary fibrosis (IPF)
This trial tests a new medication called SC1011 taken twice a day, compared to a placebo, to see if it can help people with IPF. It is for patients who were diagnosed within the last 5 years and have moderate lung function.
Beijing, Beijing MunicipalityAges 40–80 - NCT06127641Recruiting
Rehabilitation for lung disease after tuberculosis
This trial tests a pulmonary rehabilitation program for people who have ongoing lung problems after being treated for tuberculosis. It aims to help improve their breathing and physical function.
Rio de JaneiroAges 18 years+
Hear when a new Pulmonary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pulmonary?
- Yes. Clin2 currently lists 1,310 recruiting pulmonary studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pulmonary trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pulmonary trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.